Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03957473 · ClinicalTrials.gov registry record
Study of the CAT RX Aspiration Catheter When Used in Patients With Large Occlusive Thrombus in Coronary Arteries
A clinical trial, sponsored by Penumbra.
- Completed
- Registry status
- 400
- Enrollment target
NCT03957473: Completed study, sponsored by Penumbra.
NCT03957473 is a clinical trial that has completed, run by Penumbra. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03957473 has completed, sponsored by Penumbra.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
The objective of this study is to demonstrate the safety and performance of the Indigo Aspiration System using the CAT RX aspiration catheter in a population presenting with acute high thrombus burden coronary vessel occlusion who are referred for Percutaneous Coronary Intervention (PCI).
Primary Outcome
Cardiovascular death, recurrent myocardial infarction, cardiogenic shock, or new or worsening New York Heart Association Class IV heart failure
Interventions
- DEVICE Indigo Aspiration System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2019-08-22 |
| Est. Completion | 2021-06-02 |
What the finished NCT03957473 record still lists
NCT03957473 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Indigo Aspiration System is the first listed.
NCT03957473 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03957473 about?
NCT03957473 is a clinical study titled "Study of the CAT RX Aspiration Catheter When Used in Patients With Large Occlusive Thrombus in Coronary Arteries". The objective of this study is to demonstrate the safety and performance of the Indigo Aspiration System using the CAT RX aspiration catheter in a population presenting with acute high thrombus burden coronary vessel occlusion who are referred for Percutaneous Coronary Intervention (PCI).
What is the current status of trial NCT03957473?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2019-08-22. Estimated completion is 2021-06-02.
What interventions are being tested in trial NCT03957473?
The interventions under investigation include: Indigo Aspiration System (DEVICE).
Who is sponsoring clinical trial NCT03957473?
This trial is sponsored by Penumbra, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI